Different vaccine very soon available to people under 60, instead of AstraZeneca Vaccination with AstraZeneca will continue for people aged 60 years and older; the vaccine is still very necessary for that target group.
Vaccination with AstraZeneca continues for people aged 60 years and older As advised by the Health Council of the Netherlands, vaccination with AstraZeneca will be continued for people born in 1960 or before. People under the age of 60 will receive a different vaccine.
Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
New hold on vaccination with AstraZeneca for people under 60 years The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw
International collaboration essential theme State of Zoonoses 2019 Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.
Climate and Energy Outlook 2020: uncertain whether the Netherlands will achieve targets for the reduction of greenhouse gas emissions The Dutch cabinet’s goal is to reduce greenhouse gas emissions by 49% in 2030, compared to the levels in 1990.